evidence table
Pea Protein Muscle Meta-Analysis Evidence Table
Structured evidence table for Pea Protein Muscle Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Pea Protein Muscle Meta-Analysis | 3 4 Worldwide, obesity is a major public health problem associated with increased morbidity and mortality for all-causes []. | 3 | Coluzzi Flaminia (2026) | New Adjuvant Therapies for Obesity-Related Disorders Associated with Meta-Neuroinflammation |
| Pea Protein Muscle Meta-Analysis | Although obesity is recognized as a high-risk condition for the development of other chronic degenerative non-communicable diseases, this pathology has been declared as a disease per se that leads to a reduction in the quality and expectancy of life []. | 3 | Coluzzi Flaminia (2026) | New Adjuvant Therapies for Obesity-Related Disorders Associated with Meta-Neuroinflammation |
| Pea Protein Muscle Meta-Analysis | 5 3 6 7 8 In obesity patients, the adipocyte hypertrophy, visceral and ectopic adiposity, increased production of adipokines with anorexigenic function, such as leptin, and of a plethora of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin (IL)-6, IL-1β, and resistin, which predisposes the organism to the adiposopathy (or “sick fat”) []. | 3 | Coluzzi Flaminia (2026) | New Adjuvant Therapies for Obesity-Related Disorders Associated with Meta-Neuroinflammation |
| Pea Protein Muscle Meta-Analysis | 1 2 Obesity is a complex, heterogeneous, chronic, and progressive disease, which substantially affects more than 890 million (13%) adults []. | 3 | Coluzzi Flaminia (2026) | New Adjuvant Therapies for Obesity-Related Disorders Associated with Meta-Neuroinflammation |
| Pea Protein Muscle Meta-Analysis | According to the internationally used definition, MetS is characterized by having at least three out of several possible risk factors, including high blood pressure, hypertriglyceridemia, low levels of HDL cholesterol, elevated fasting glucose, and central obesity (). | 3 | Wang Song-nan (2026) | Branched-chain amino acids from plants and the metabolic syndrome: pathways and pharmacological applications |
| Pea Protein Muscle Meta-Analysis | α p p 6 7 9 9 10 6 High levels of TNF-, IL-6, and CRP are associated with insulin resistance, endothelial dysfunction, and atherogenesis (,,). | 3 | Wang Song-nan (2026) | Branched-chain amino acids from plants and the metabolic syndrome: pathways and pharmacological applications |
| Pea Protein Muscle Meta-Analysis | Such increases appear to be closely linked to MetS, type 2T2DM, and CVD risk (,). | 3 | Wang Song-nan (2026) | Branched-chain amino acids from plants and the metabolic syndrome: pathways and pharmacological applications |
| Pea Protein Muscle Meta-Analysis | 1 1 The metabolic syndrome (MetS), one of the most significant public health problems of the 21st century, is characterized by central obesity, insulin resistance, hypertension, and dyslipidemia. | 3 | Wang Song-nan (2026) | Branched-chain amino acids from plants and the metabolic syndrome: pathways and pharmacological applications |
Source documents